These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 29200888)
1. Prognostic and clinicopathological value of Ki-67/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals. Wang Z; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y Cancer Manag Res; 2017; 9():679-689. PubMed ID: 29200888 [TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis. Wang Z; Peng S; Jiang N; Wang A; Liu S; Xie H; Guo L; Cai Q; Niu Y Oncotarget; 2017 Nov; 8(60):102361-102370. PubMed ID: 29254251 [TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis. Xie Y; Chen L; Ma X; Li H; Gu L; Gao Y; Fan Y; Zhang Y; Zhang X Sci Rep; 2017 Mar; 7():44281. PubMed ID: 28287186 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma. Wang Z; Peng S; Guo L; Xie H; Wang A; Shang Z; Niu Y Clin Chim Acta; 2018 Nov; 486():9-17. PubMed ID: 30006290 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value and clinicopathological features of sarcomatoid differentiation in patients with renal cell carcinoma: a systematic review and meta-analysis. Zhang L; Wu B; Zha Z; Zhao H; Feng Y Cancer Manag Res; 2018; 10():1687-1703. PubMed ID: 29970967 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals. Wang Z; Peng S; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y Clin Exp Med; 2018 May; 18(2):165-175. PubMed ID: 29362922 [TBL] [Abstract][Full Text] [Related]
7. The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis. Pan D; Wei K; Ling Y; Su S; Zhu M; Chen G Med Sci Monit; 2015 Mar; 21():882-9. PubMed ID: 25807305 [TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological value of Ki-67 expression in patients with nasopharyngeal carcinoma: a meta-analysis. Shi Z; Jiang W; Chen X; Xu M; Wang X; Zha D Ther Adv Med Oncol; 2020; 12():1758835920951346. PubMed ID: 33014147 [TBL] [Abstract][Full Text] [Related]
9. The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases. Pan DH; Wen DY; Luo YH; Chen G; Yang H; Chen JQ; He Y Onco Targets Ther; 2017; 10():3261-3276. PubMed ID: 28740401 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Ki-67/MIB-1 Expression in Meningioma Patients: A Meta-Analysis. Li J; Liang R; Song C; Xiang Y; Liu Y Crit Rev Eukaryot Gene Expr; 2019; 29(2):141-150. PubMed ID: 31679269 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study. Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis. Luo Y; Ren F; Liu Y; Shi Z; Tan Z; Xiong H; Dang Y; Chen G Int J Clin Exp Med; 2015; 8(7):10235-47. PubMed ID: 26379815 [TBL] [Abstract][Full Text] [Related]
13. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis. Pu Z; Wang Q; Xie H; Wang G; Hao H Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and Clinicopathological Value of Ki-67 in Melanoma: A Meta-Analysis. Liu Q; Peng Z; Shen L; Shen L Front Oncol; 2021; 11():737760. PubMed ID: 34568073 [TBL] [Abstract][Full Text] [Related]
15. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of albumin-to-globulin ratio in patients with renal cell carcinoma: a meta-analysis. Mao H; Yang F Front Oncol; 2023; 13():1210451. PubMed ID: 37538115 [TBL] [Abstract][Full Text] [Related]
17. The Prognostic Role of Ki-67/MIB-1 in Upper Urinary-Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis. Lei Y; Li Z; Qi L; Tong S; Li B; He W; Chen M J Endourol; 2015 Nov; 29(11):1302-8. PubMed ID: 26083161 [TBL] [Abstract][Full Text] [Related]
18. Prognostic and Clinicopathological Significance of the Systemic Immune-Inflammation Index in Patients With Renal Cell Carcinoma: A Meta-Analysis. Jin M; Yuan S; Yuan Y; Yi L Front Oncol; 2021; 11():735803. PubMed ID: 34950577 [TBL] [Abstract][Full Text] [Related]
19. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis. Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026 [TBL] [Abstract][Full Text] [Related]
20. Impact of p53, MIB-1 and PECAM-1 expression on the prognosis of urothelial carcinoma of the renal pelvis. García-Tello A; Angulo JC; Andrés G; Ramón de Fata F; Sánchez-Chapado M; López JI Actas Urol Esp; 2014 Oct; 38(8):506-14. PubMed ID: 24702909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]